The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells
Open accessAbstract
Cancer stem cells (CSCs) display plasticity and self-renewal properties reminiscent of normal tissue stem cells, but the events responsible for their emergence remain obscure. We recently identified CSCs in Ewing sarcoma family tumors (ESFTs) and showed that they retain mesenchymal stem cell (MSC) plasticity. In the present study, we addressed the mechanisms that underlie ESFT CSC development. We show that the EWS-FLI-1 fusion gene, associated with 85%–90% of ESFTs and believed to initiate their pathogenesis, induces expression of the embryonic stem cell (ESC) genes OCT4 , SOX2 , and NANOG in human pediatric MSCs (hpMSCs) but not in their adult counterparts. Moreover, under appropriate culture conditions, hpMSCs expressing EWS-FLI-1 generate a cell subpopulation displaying ESFT CSC features in vitro. We further demonstrate that induction of the ESFT CSC phenotype is the result of the combined effect of EWS-FLI-1 on its target gene expression and repression of microRNA-145 (miRNA145) promoter activity. Finally, we provide evidence that EWS-FLI-1 and miRNA-145 function in a mutually repressive feedback loop and identify their common target gene, SOX2 , in addition to miRNA145 itself, as key players in ESFT cell differentiation and tumorigenicity. Our observations provide insight for the first time into the mechanisms whereby a single oncogene can reprogram primary cells to display a CSC phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Neurotrophin-regulated signalling pathways
Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Breitling, R., Armengaud, P., Amtmann, A., & Herzyk, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.055 · Cited by 1,496
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
SOX2 Functions to Maintain Neural Progenitor Identity
Graham, V., Khudyakov, J., Ellis, P., & Pevny, L. (2003) · Neuron · doi:10.1016/s0896-6273(03)00497-5 · Cited by 1,341
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J. A., & Kosik, K. S. (2009) · Cell · doi:10.1016/j.cell.2009.02.038 · Cited by 1,124
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028 · cited 1×
“In addition, recent observations suggest that two major tumor suppressor genes, INK4A and TP53, impair efficient iPS generation (Banito et al. 2009; Kawamura et al. 2009; Marion et al. 2009), consistent with the existence of a relationship between genetic reprogramming and transformation.”
BackgroundSOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Bass, A. J., Watanabe, H., Mermel, C. H., Yu, S., Perner, S., Verhaak, R. G., Kim, S. Y., Wardwell, L., Tamayo, P., Gat-Viks, I., et al. (2009) · Nature Genetics · doi:10.1038/ng.465 · Cited by 942
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis
Hong, F., Breitling, R., McEntee, C. W., Wittner, B. S., Nemhauser, J. L., & Chory, J. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl476 · Cited by 752
Ellis, P., Fagan, B. M., Magness, S. T., Hutton, S., Taranova, O., Hayashi, S., McMahon, A., Rao, M., & Pevny, L. (2004) · Developmental Neuroscience · doi:10.1159/000082134 · Cited by 742
Senescence impairs successful reprogramming to pluripotent stem cells
Banito, A., Rashid, S. T., Acosta, J. C., Li, S., Pereira, C. F., Geti, I., Pinho, S., Silva, J. C., Azuara, V., Walsh, M., et al. (2009) · Genes & Development · doi:10.1101/gad.1811609 · Cited by 642
Neuroepithelial Cells Supply an Initial Transient Wave of MSC Differentiation
Takashima, Y., Era, T., Nakao, K., Kondo, S., Kasuga, M., Smith, A. G., & Nishikawa, S.-I. (2007) · Cell · doi:10.1016/j.cell.2007.04.028 · Cited by 523
Mesenchymal Stem Cell Features of Ewing Tumors
Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P., & Delattre, O. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.027 · Cited by 507
Guidelines and Techniques for the Generation of Induced Pluripotent Stem Cells
Maherali, N., & Hochedlinger, K. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.008 · Cited by 486
Targeting the RAF–MEK–ERK pathway in cancer therapy
Montagut, C., & Settleman, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.022 · Cited by 468
Mechanisms of sarcoma development
Helman, L. J., & Meltzer, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1168 · Cited by 460
Molecules that Promote or Enhance Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells
Feng, B., Ng, J.-H., Heng, J.-C. D., & Ng, H.-H. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.005 · Cited by 381
Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
Riggi, N., Cironi, L., Provero, P., Suvà, M.-L., Kaloulis, K., Garcia-Echeverria, C., Hoffmann, F., Trumpp, A., & Stamenkovic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1696 · Cited by 359
Self-citationGene expression profiling of human sarcomas: insights into sarcoma biology.
Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1699 · Cited by 353 · cited 6×
“Comparison of the gene expression profile of these cells to a primary sarcoma gene expression database (Baird et al. 2005) revealed highly significant similarity with the transcriptome of Ewing sarcoma (Fig.”
BackgroundMethodResultInfluentialRiggi, N., Suvà, M.-L., Suvà, D., Cironi, L., Provero, P., Tercier, S., Joseph, J.-M., Stehle, J.-C., Baumer, K., Kindler, V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1761 · Cited by 332
Self-citationRegulation of Self-Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells
Fong, H., Hohenstein, K. A., & Donovan, P. J. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1002 · Cited by 304
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
Jänne, P. A., Gray, N., & Settleman, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2871 · Cited by 303
Identification of Cancer Stem Cells in Ewing's Sarcoma
Suvà, M.-L., Riggi, N., Stehle, J.-C., Baumer, K., Tercier, S., Joseph, J.-M., Suvà, D., Clément, V., Provero, P., Cironi, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2242 · Cited by 302
Self-citationRiggi, N., & Stamenkovic, I. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.009 · Cited by 282
Self-citationLessnick, S. L., Dacwag, C. S., & Golub, T. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00056-9 · Cited by 264
TrkA overexpression enhances growth and metastasis of breast cancer cells
Lagadec, C., Meignan, S., Adriaenssens, E., Foveau, B., Vanhecke, E., Romon, R., Toillon, R. A., Oxombre, B., Hondermarck, H., & Le Bourhis, X. (2009) · Oncogene · doi:10.1038/onc.2009.61 · Cited by 235
Staege, M. S., Hutter, C., Neumann, I., Foja, S., Hattenhorst, U. E., Hansen, G., Afar, D., & Burdach, S. E. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4059 · Cited by 213
Dauphinot, L., De Oliveira, C., Melot, T., Sevenet, N., Thomas, V., Weissman, B. E., & Delattre, O. (2001) · Oncogene · doi:10.1038/sj.onc.1204437 · Cited by 172
Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET
Riggi, N., Cironi, L., Suvà, M., & Stamenkovic, I. (2007) · The Journal of Pathology · doi:10.1002/path.2209 · Cited by 154
Self-citationLoss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation
Deneen, B., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204875 · Cited by 144
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines
Dirks, W. G., Fähnrich, S., Lis, Y., Becker, E., MacLeod, R. A. F., & Drexler, H. G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10435 · Cited by 125
A Multiplex Real-Time PCR Assay for the Detection of Gene Fusions Observed in Solid Tumors
Peter, M., Gilbert, E., & Delattre, O. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780299 · Cited by 125
Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
Ordóñez, J. L., Osuna, D., Herrero, D., de Álava, E., & Madoz‐Gúrpide, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4041 · Cited by 122
IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells
Cironi, L., Riggi, N., Provero, P., Wolf, N., Suvà, M.-L., Suvà, D., Kindler, V., & Stamenkovic, I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002634 · Cited by 118
Self-citationNon‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells
Suvà, D., Garavaglia, G., Ménétrey, J., Chapuis, B., Hoffmeyer, P. J., Bernheim, L., & Kindler, V. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10396 · Cited by 116
Self-citationHuman neural crest cells display molecular and phenotypic hallmarks of stem cells
Thomas, S., Thomas, M. K., Wincker, P., Babarit, C., Xu, P., Speer, M. C., Münnich, A., Lyonnet, S., Vekemans, M. J. J., & Etchevers, H. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn235 · Cited by 115
Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis
Argiropoulos, B., Yung, E., & Humphries, R. K. (2007) · Genes & Development · doi:10.1101/gad.1619407 · Cited by 101
Liu, Y., Clem, B. F., Zuba‐Surma, E. K., El‐Naggar, S., Telang, S., Jenson, A. B., Wang, Y., Shao, H., Ratajczak, M. Z., Chesney, J. A., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.02.015 · Cited by 97
Cholecystokinin Down-Regulation by RNA Interference Impairs Ewing Tumor Growth
Carrillo, J., García-Aragoncillo, E., Azorín, D., Agrá, N., Sastre, A., González‐Mediero, I., García‐Miguel, P., Pestaña, Á., Gallego, S., Segura, D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1762 · Cited by 86
DNA Binding Domain-independent Pathways Are Involved in EWS/FLI1-mediated Oncogenesis
Welford, S. M., Hebert, S. P., Deneen, B., Arvand, A., & Denny, C. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106757200 · Cited by 65
Stimulation of Oct‐4 Activity by Ewing's Sarcoma Protein
Lee, J., Rhee, B. K., Bae, G., Han, Y., & Kim, J. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0375 · Cited by 63
Suvà, D., Passweg, J. R., Arnaudeau, S., Hoffmeyer, P. J., & Kindler, V. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21244 · Cited by 52
Self-citationMembrane‐associated phospholipase A1 beta (LIPI) Is an Ewing tumour‐associated cancer/testis antigen
Foell, J. L., Hesse, M., Volkmer, I., Schmiedel, B. J., Neumann, I., & Staege, M. S. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21602 · Cited by 43
Abate and Switch: miR-145 in Stem Cell Differentiation
Chivukula, R. R., & Mendell, J. T. (2009) · Cell · doi:10.1016/j.cell.2009.04.059 · Cited by 43
(2003) · PubMed
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Epigenetic reprogramming in cancer
Suvà, M. L., Riggi, N., & Bernstein, B. E. (2013) · Science · doi:10.1126/science.1230184 · Cited by 706
Self-citationCancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Dedifferentiation and reprogramming: origins of cancer stem cells
Friedmann‐Morvinski, D., & Verma, I. M. (2014) · EMBO reports · doi:10.1002/embr.201338254 · Cited by 495
Riggi, N., Knoechel, B., Gillespie, S. M., Rheinbay, E., Boulay, G., Suvà, M. L., Rossetti, N. E., Boonseng, W. E., Oksuz, O., Cook, E. B., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.004 · Cited by 445
Self-citation
Metadata
- Authors
- Riggi, N., Suvà, M.-L., De Vito, C., Provero, P., Stehle, J.-C., Baumer, K., Cironi, L., Janiszewska, M., Petricevic, T., Suvà, D., Tercier, S., Joseph, J.-M., Guillou, L., & Stamenkovic, I.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-04-09
- Volume
- 24
- Issue
- 9
- Pages
- 916-932
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2122271136
- Cited by
- 279
- References
- 51
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.